Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, February 25, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - MONDAY, JULY 11TH, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 31213.23 -124.92 (-0.40%) | NASDAQ 11413.3 -222.01 (-1.91%) | S&P 500 3859.9 -39.48 (-1.01%)
Time of Screening : 7/11/2022 12:33:50 PM         Report Released : 7/11/2022 1:23:58 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 45% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page


NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.


Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
AZN - NYSE - DRUGS - Drug Manufacturers - Major
Astrazeneca Plc Ads
$67.40 +0.42
0.62%
$67.40 $71.70 -6.00% 3,566,211
50.58%
7,051,000
Most Recent Note for AZN - 7/11/2022 12:37:32 PM
Consolidating above its 50 DMA line after finding support near its 200 DMA line. Little resistance remains due to overhead supply up to the $71 level. Prior mid-day reports noted - "Prior quarterly and annual earnings history is not a match with the fundamental guidelines of the fact-based investment system."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CNC - NYSE - HEALTH SERVICES - Health Care Plans
Centene Corp
$87.83 -0.19
-0.21%
$88.37 $89.92 -2.33% 1,375,618
45.81%
3,003,000
Most Recent Note for CNC - 7/11/2022 12:42:21 PM
Rallied near its 52-week high with big gain on the prior session when noted in the mid-day report - "Rebounded impressively since finding prompt support near its 200 DMA line. Reported earnings +12% on +24% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Annual earnings history (A criteria) has been steady. Shares split 2:1 on 2/07/19 and also 2:1 back on 2/20/15. Completed a new Public Offering on 5/03/18."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
DGICA - NASDAQ - Insurance-Prop/Cas/Titl
Donegal Group Inc Cl A
$16.76 +0.00
0.00%
$16.84 $17.13 -2.16% 48,548
45.80%
106,000
Most Recent Note for DGICA - 7/11/2022 12:52:32 PM
Hovering near its 52-week high following volume-driven gains. Prior mid-day reports noted - "Reported earnings +48% on +5% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly sales revenues and earnings growth has not been strong and steady. Annual earnings (A criteria) history also has been up and down."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
EBF - NYSE - CONSUMER NON-DURABLES - Office Supplies
Ennis Inc
$19.93 +0.01
0.03%
$20.11 $21.18 -5.93% 72,840
70.04%
104,000
Most Recent Note for EBF - 7/11/2022 12:58:20 PM
Rebounded quickly from the recent low with a spurt of big volume-driven gains. The Feb and May '22 quarterly comparisons showed stronger earnings increases. Prior quarterly and annual earnings (C and A criteria) are not a match with the fundamental guidelines of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ELA - AMEX - Retail/Whlsle-Jewelry
Envela Corporation
$7.59 +0.34
4.67%
$7.70 $7.35 3.24% 81,483
104.47%
78,000
Most Recent Note for ELA - 7/11/2022 1:18:01 PM
Hitting a new 52-week and all time high with today's gain. Reported strong Mar '22 quarterly results versus the year ago period. Went through a deep consolidation from its high since noted with caution in the 2/01/21 mid-day report - "Prior earnings history has been erratic and not a match with the fact-based investment system's fundamental guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
IBN - NYSE - BANKING - Money Center Banks
Icici Bank Ltd Adr
$19.26 +0.01
0.03%
$19.43 $22.34 -13.81% 4,374,221
53.21%
8,221,000
Most Recent Note for IBN - 7/11/2022 1:21:08 PM
This India-based bank's sales revenues and earnings have not shown strong or steady quarterly and annual growth or acceleration.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MUSA - NYSE - WHOLESALE - Basic Materials Wholesale
Murphy USA Inc
$265.49 +10.36
4.06%
$265.93 $262.58 1.11% 184,390
50.66%
364,000
Most Recent Note for MUSA - 7/11/2022 1:23:14 PM
Hitting a new all-time high with today's 7th consecutive gain. Reported earnings +202% on +45% sales revenues for the Mar '22 quarter versus the year ago period, its 3rd strong quarterly comparison. Fundamental concerns remain as its prior quarterly and annual earnings (C and A criteria) history is not a great match with the fact-based investment system's guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
USAK - NASDAQ - TRANSPORTATION - Trucking
U S A Truck Inc
$31.14 +0.05
0.14%
$31.29 $31.67 -1.69% 147,825
54.75%
270,000
Most Recent Note for USAK - 7/11/2022 1:23:26 PM
Holding its ground after a gap up on 6/24/22 M&A news. Recent quarterly comparisons through Mar '22 were strong but its prior earnings history is not a match with the fundamental guidelines of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
VIVO - NASDAQ - DRUGS - Diagnostic Substances
Meridian Bioscience Inc
$33.00 +0.00
0.00%
$33.20 $34.38 -4.01% 1,123,997
173.19%
649,000
Most Recent Note for VIVO - 7/11/2022 1:23:51 PM
Perched near its 52-week high following volume-driven gains after M&A news this week. Prior mid-day reports cautioned members - "Quarterly earnings increases through Mar '22 versus the year ago periods have been below the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines. On 4/18/08 it was dropped from the Featured Stocks list."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us